Abhay Joshi

2021

In 2021, Abhay Joshi earned a total compensation of $2.6M as Chief Operating Officer, President of R&D and Product Operations at Revance Therapeutics, a 36% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$154,081
Option Awards$634,014
Salary$519,754
Stock Awards$1,267,172
Other$11,738
Total$2,586,759

Joshi received $1.3M in stock awards, accounting for 49% of the total pay in 2021.

Joshi also received $154.1K in non-equity incentive plan, $634K in option awards, $519.8K in salary and $11.7K in other compensation.

Rankings

In 2021, Abhay Joshi's compensation ranked 5,029th out of 12,405 executives tracked by ExecPay. In other words, Joshi earned more than 59.5% of executives.

ClassificationRankingPercentile
All
5,029
out of 12,405
60th
Division
Manufacturing
2,116
out of 5,494
62nd
Major group
Chemicals And Allied Products
903
out of 2,369
62nd
Industry group
Drugs
808
out of 2,090
61st
Industry
Pharmaceutical Preparations
577
out of 1,537
63rd

Pay ratio

Abhay Joshi's Pay$2,586,759
Median Employee's Pay$248,326
Pay Ratio

10

to 1

In 2021, the annual total compensation of Abhay Joshi was $2,586,759.

The annual total compensation of the median employee at Revance Therapeutics was $248,326.

The ratio of Abhay Joshi's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on March 24, 2022.

Joshi's colleagues

We found four more compensation records of executives who worked with Abhay Joshi at Revance Therapeutics in 2021.

2021

Mark Foley

Revance Therapeutics

Chief Executive Officer

2021

Dustin Sjuts

Revance Therapeutics

President

2021

Aubrey Rankin

Revance Therapeutics

Former President, Innovation & Technology

2021

Tobin Schilke

Revance Therapeutics

Chief Financial Officer

News

You may also like